Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1338-42.